TROPONIX ENERGY PRIVATE LIMITED

In their own words

"Troponix is revolutionizing cardiac care with U-Tropia, a non-invasive, AI-powered wearable that continuously monitors troponin levels and ECG signals to detect heart attacks and cardiac events in real time. By combining cutting-edge biosensors, machine learning, and telemedicine, Troponix shifts cardiac diagnostics from reactive to proactive, improving early detection and patient outcomes. Key Innovations: Nanostructured graphene-gold electrodes detecting troponin at 3.2 ng/L. Edge AI with federated learning for accurate readings despite motion and noise. Microfluidic sweat analysis with 91% correlation to blood troponin levels. On-device processing enabling >94% diagnostic accuracy without cloud reliance. Target Markets: $12B global cardiac diagnostics market with a first-mover edge in continuous troponin monitoring. $4.2B wearable medical devices sector, pursuing FDA De Novo approval (Q2 2025). Value-based care partnerships with a 66% cost-reduction model. Mission: Combat heart disease through early diagnosis. Vision: Decentralize heart health diagnostics to improve patient outcomes globally. Ethos: Driven by innovation and purpose, Troponix is redefining the future of cardiac diagnostics—because every heartbeat matters."

Written by the company on its public Startup India profile. Not verified by us.